TCI Wealth Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

TCI Wealth Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-215	Closed	-$4K	–	2633
2022 Q1	$4K	Buy	+215	New	+$3.87K	﹤0.01%	1844
2021 Q4	–	Sell	-214	Closed	-$4K	–	2620
2021 Q3	$4K	Buy	+214	New	+$4.31K	﹤0.01%	1870

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TCI Wealth Advisors's OCDX Position: Q2 2022 in Review

TCI Wealth Advisors sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 215 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in OCDX in Q3 2021 and held it in 2 quarters. The position peaked at $4K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

TCI Wealth Advisors reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
TCI Wealth Advisors sold 215 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $4K.
TCI Wealth Advisors first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 2 quarters.
TCI Wealth Advisors's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $4K in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on TCI Wealth Advisors's 13F filing for Q2 2022, filed 19 Jul 2022.